This sounds like a really interesting molecule, has anybody heard of it?
2 Likes
Heber-Katz has patented the use of 1,4-DPCA for tissue regeneration and co-founded MRL Bio, a company dedicated to translating their laboratory successes into real-world applications. Despite skepticism from some biologists about the complexity of true regeneration in mammals, Heber-Katz remains optimistic, emphasizing the drug’s ability to promote the growth of healthy new cells. The next steps involve testing the drug in larger animals, with eventual aspirations for human studies.
1 Like
This is great. Sounds like it has a lot of applications. I’m guessing it’s going to have to be localized for wound healing. It may end up having cosmetic applications for scarless surgeries. Amazing.
1 Like